217 related articles for article (PubMed ID: 25170571)
1. Advancing novel anesthetics: pharmacodynamic and pharmacokinetic studies of cyclopropyl-methoxycarbonyl metomidate in dogs.
Campagna JA; Pojasek K; Grayzel D; Randle J; Raines DE
Anesthesiology; 2014 Dec; 121(6):1203-16. PubMed ID: 25170571
[TBL] [Abstract][Full Text] [Related]
2. Adrenocortical suppression and recovery after continuous hypnotic infusion: etomidate versus its soft analogue cyclopropyl-methoxycarbonyl metomidate.
Ge R; Pejo E; Cotten JF; Raines DE
Crit Care; 2013 Jan; 17(1):R20. PubMed ID: 23363638
[TBL] [Abstract][Full Text] [Related]
3. Distinct Hypnotic Recoveries After Infusions of Methoxycarbonyl Etomidate and Cyclopropyl Methoxycarbonyl Metomidate: The Role of the Metabolite.
Pejo E; Liu J; Lin X; Raines DE
Anesth Analg; 2016 Apr; 122(4):1008-14. PubMed ID: 26991617
[TBL] [Abstract][Full Text] [Related]
4. Sedative-hypnotic Binding to 11β-hydroxylase.
Pejo E; Zhou X; Husain SS; Raines DE
Anesthesiology; 2016 Nov; 125(5):943-951. PubMed ID: 27541316
[TBL] [Abstract][Full Text] [Related]
5. The pharmacology of cyclopropyl-methoxycarbonyl metomidate: a comparison with propofol.
Ge R; Pejo E; Gallin H; Jeffrey S; Cotten JF; Raines DE
Anesth Analg; 2014 Mar; 118(3):563-7. PubMed ID: 24557104
[TBL] [Abstract][Full Text] [Related]
6. Electroencephalographic and hypnotic recoveries after brief and prolonged infusions of etomidate and optimized soft etomidate analogs.
Ge R; Pejo E; Husain SS; Cotten JF; Raines DE
Anesthesiology; 2012 Nov; 117(5):1037-43. PubMed ID: 22929726
[TBL] [Abstract][Full Text] [Related]
7. Safety and clinical effect of i.v. infusion of cyclopropyl-methoxycarbonyl etomidate (ABP-700), a soft analogue of etomidate, in healthy subjects.
Valk BI; Absalom AR; Meyer P; Meier S; den Daas I; van Amsterdam K; Campagna JA; Sweeney SP; Struys MMRF
Br J Anaesth; 2018 Jun; 120(6):1401-1411. PubMed ID: 29793605
[TBL] [Abstract][Full Text] [Related]
8. Cyclopropyl-methoxycarbonyl Metomidate: Studies in a Lipopolysaccharide Inflammatory Model of Sepsis.
Santer P; Pejo E; Feng Y; Chao W; Raines DE
Anesthesiology; 2015 Aug; 123(2):368-76. PubMed ID: 26035348
[TBL] [Abstract][Full Text] [Related]
9. Analogues of etomidate: modifications around etomidate's chiral carbon and the impact on in vitro and in vivo pharmacology.
Pejo E; Santer P; Jeffrey S; Gallin H; Husain SS; Raines DE
Anesthesiology; 2014 Aug; 121(2):290-301. PubMed ID: 24777068
[TBL] [Abstract][Full Text] [Related]
10. Methoxycarbonyl-etomidate: a novel rapidly metabolized and ultra-short-acting etomidate analogue that does not produce prolonged adrenocortical suppression.
Cotten JF; Husain SS; Forman SA; Miller KW; Kelly EW; Nguyen HH; Raines DE
Anesthesiology; 2009 Aug; 111(2):240-9. PubMed ID: 19625798
[TBL] [Abstract][Full Text] [Related]
11. An Etomidate Analogue With Less Adrenocortical Suppression, Stable Hemodynamics, and Improved Behavioral Recovery in Rats.
Wang B; Yang J; Chen J; Kang Y; Yang LH; Liu J; Zhang WS
Anesth Analg; 2017 Aug; 125(2):442-450. PubMed ID: 28514325
[TBL] [Abstract][Full Text] [Related]
12. Closed-loop continuous infusions of etomidate and etomidate analogs in rats: a comparative study of dosing and the impact on adrenocortical function.
Cotten JF; Le Ge R; Banacos N; Pejo E; Husain SS; Williams JH; Raines DE
Anesthesiology; 2011 Oct; 115(4):764-73. PubMed ID: 21572317
[TBL] [Abstract][Full Text] [Related]
13. Electroencephalographic recovery, hypnotic emergence, and the effects of metabolite after continuous infusions of a rapidly metabolized etomidate analog in rats.
Pejo E; Ge R; Banacos N; Cotten JF; Husain SS; Raines DE
Anesthesiology; 2012 May; 116(5):1057-65. PubMed ID: 22417966
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological studies of methoxycarbonyl etomidate's carboxylic acid metabolite.
Ge RL; Pejo E; Haburcak M; Husain SS; Forman SA; Raines DE
Anesth Analg; 2012 Aug; 115(2):305-8. PubMed ID: 22052979
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro pharmacological studies of methoxycarbonyl-carboetomidate.
Pejo E; Cotten JF; Kelly EW; Le Ge R; Cuny GD; Laha JK; Liu J; Lin XJ; Raines DE
Anesth Analg; 2012 Aug; 115(2):297-304. PubMed ID: 21965364
[TBL] [Abstract][Full Text] [Related]
16. Anesthetic Drug Discovery and Development: A Case Study of Novel Etomidate Analogs.
McGrath M; Raines DE
Methods Enzymol; 2018; 603():153-169. PubMed ID: 29673523
[TBL] [Abstract][Full Text] [Related]
17. A Novel Etomidate Analog EL-0052 Retains Potent Hypnotic Effect and Stable Hemodynamics without Suppressing Adrenocortical Function.
Xu X; Wei Y; Dong Y; Qiu Y; Mei Z; Wang K; Xiu J; Wang T; Zeng L; Dong X; Shen Y; Jiang W; Li Q
J Pharmacol Exp Ther; 2021 Dec; 379(3):324-330. PubMed ID: 34521699
[TBL] [Abstract][Full Text] [Related]
18. Modifying methoxycarbonyl etomidate inter-ester spacer optimizes in vitro metabolic stability and in vivo hypnotic potency and duration of action.
Husain SS; Pejo E; Ge R; Raines DE
Anesthesiology; 2012 Nov; 117(5):1027-36. PubMed ID: 22929736
[TBL] [Abstract][Full Text] [Related]
19. A Phase 1, Single-center, Double-blind, Placebo-controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Clinical Effects, and Pharmacokinetics-Pharmacodynamics of Intravenous Cyclopropyl-methoxycarbonylmetomidate (ABP-700) after a Single Ascending Bolus Dose.
Struys MMRF; Valk BI; Eleveld DJ; Absalom AR; Meyer P; Meier S; den Daas I; Chou T; van Amsterdam K; Campagna JA; Sweeney SP
Anesthesiology; 2017 Jul; 127(1):20-35. PubMed ID: 28459733
[TBL] [Abstract][Full Text] [Related]
20. Etomidate derivatives: Novel pharmaceutical agents in anesthesia.
Malapero RJ; Zaccagnino MP; Brovman EY; Kaye AD; Urman RD
J Anaesthesiol Clin Pharmacol; 2017; 33(4):429-431. PubMed ID: 29416230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
